Interesting post on X and vimeo. I don't think Oncosil CEO Nigel Lange could spell it out any more that this vimeo. The major aim is setting Oncosil up as a take over and they have the team experience to achieve this as they have done it before. Nigel Lange was Sirtex CEO for Europe .
CEO Nigel can see Oncosil going in a similar path as Sirtex and can see very strong parallels. The experience of the Oncosil team, almost all of them come from Sirtex or Sirex competitor BTG. They have been able to pick from the best of the best and are looking for a similar experience with Oncosil. They are now on their way of achieving this. Sirtex to his knowledge is still the largest biotech acquisition in Australia which was taken over for $1.9 Billion.
Oncosil is still trading around a $40 to $50 million market cap. With already improving sales, further expansion, approvals and more high impact news to follow soon, forward thinking markets are yet to see it.
This is brief summary of part of the vimeo presentation.. Watch for yourself using the below URL from X and come to your own conclusions.
